In addition, the purified recombinant HAI-2 proteins exhibit an inhibitory activity against plasmin and NSCLC invasion, suggesting a therapeutic potential of HAI-2 in targeting plasmin and suppression of NSCLC metastasis. The gene discussed is PLG; the disease is non-small cell lung carcinoma.